About

World-class protein design innovators backed by top-tier global investors.

Leadership

Members of the scientific team at Cyrus have published some of the seminal demonstrations of protein structure prediction, protein AI algorithm development and protein/protein interaction design in numerous programs at the Institute for Protein Design (IPD) and other institutions. The team has worked on computational discovery and novel IP for over 30 partner firms including Janssen, Genentech, Nimbus, and Selecta. The executive team brings experience from multiple INDs, large BD transactions and biotech IPOs, complementing the scientific innovation at Cyrus.

Management

Lucas Nivon

Chief Executive Officer

Erik Procko

Chief Scientific Officer

Mark Benjamin

President & EVP

Business Development

Eric Tarcha

SVP of Development

Yifan Song

Chief Technology Officer

Gabor Illei​

Senior Clinical Advisor​

Scientific Advisors

David Baker

Scientific Co-Founder

& Advisor

Will Chen

Scientific Advisor

Mohammed AlQuraishi

Scientific Advisor

Manuel Baca

Scientific Advisor

Derek Pociask

Scientific Advisor

Board of Directors

Eric Bell

Board Observer

Lucas Nivon

Chief Executive Officer & Board Member

Geeta Vemuri

Board Observer

Yifan Song

Chief Technology Officer & Board Member

Chad Waite

Board Member

Carl Gordon

Board Observer

Ting Xie

Board Observer

Jason Smith

Board Member

Schwark Satyavolu

Board Member

Eric Larsen

Board Observer

Anthony Manning

Board Member

Investors

Cyrus is backed by a number of largest global VC firms in biotechnology, as well as major Tech investors and local seed investors in Seattle.